Memphis, Tenn. – Sept. 30, 2010 – Christie Medical Holdings, makers of the VeinViewer® imaging system, were recently honored by Tennessee Gov. Phil Bredesen and Matt Kisber, Economic and Community Development Commissioner, in the small business category for the Governor’s Award for Trade Excellence (GATE). The GATE award recognizes small, medium and large companies for demonstrating excellence through expansion of global trade.

Christie Medical Holdings (formerly Luminetx) began global distribution in the spring of 2008 with their second generation product, VeinViewerGS (Global Standard), quickly growing their footprint to include representation in over 40 countries around the world. In May of this year, the company announced the launch of their 3rd generation product, VeinViewer Vision, which boasts a 60% reduction in size, enhanced features, battery power and a lower price point. In the last 30 days, Christie Medical Holdings has brought on two new international partners and expects another 10 before the end of the year.

VeinViewer uses near-infrared light and other patented technologies to project a real-time digital image of patient vasculature directly on the surface of the skin. Designed for assistance in IV starts and blood draws, VeinViewer is also beneficial in the process of spider and varicose vein treatment.

About Christie Medical Innovations

Christie Medical Innovations formerly Luminetx® Corporation, is a global company based in Memphis, Tenn. that discovers, develops and commercializes medical technologies. The company’s market leading product, VeinViewer®, is a mobile vascular imaging system that allows health care providers to clearly see accessible vasculature in real time directly on the surface of the skin. Christie Medical Holdings is owned by Christie Digital Systems, Inc. a global visual technologies company and a subsidiary of Ushio, Inc., Japan (JP:6925). For more information on Christie or Christie Medical Holdings, visit